Molbio Diagnostics IPO GMP Today — Live Grey Market Premium & Estimated Listing Price

Updated 4 Aug 2026  ·  10:02 AM IST  ·  Live grey market data

Molbio Diagnostics IPO GMP Today — Quick Summary

Affiliate disclosure: we earn a small commission if you open an account through this link, at no extra cost to you.

Live Grey Market Premium — Molbio Diagnostics IPO

GMP Sentiment: No significant grey market activity yet. Neutral signal.

What is Molbio Diagnostics IPO Grey Market Premium? The Grey Market Premium (GMP) for Molbio Diagnostics IPO today is ₹0. This means grey market traders are paying ₹0 above the issue price of ₹—, expecting the stock to list around ₹— — an estimated listing gain of —.
GMP is unofficial and unregulated by SEBI — it is not a guarantee of listing price.
Read our complete GMP guide →

Molbio Diagnostics IPO Details

Is Molbio Diagnostics IPO Worth Applying Based on GMP?

• ⚠ GMP is neutral — bearish or neutral grey market signal. Proceed with caution.
• 📊 Always check PAT growth, P/E ratio vs listed peers, debt levels, and promoter holding before applying. GMP is unofficial sentiment — not investment advice.
• 📋 Check QIB subscription level — strong QIB participation (above 10x) indicates institutional confidence and reduces listing risk.

Affiliate link. We may earn a commission at no extra cost to you. Investment in securities is subject to market risk.

Frequently Asked Questions — Molbio Diagnostics IPO GMP

Q: What is the current GMP of Molbio Diagnostics IPO today?

As of 4 Aug 2026, the Grey Market Premium (GMP) for Molbio Diagnostics IPO is ₹0. With the upper price band set at ₹—, the estimated listing price is ₹— — an expected —. GMP is updated multiple times daily during market hours.

Q: What is the estimated listing price for Molbio Diagnostics IPO?

The expected listing price is calculated as: Issue Price + Today’s GMP = Expected Listing Price.
₹— (Issue Price) + ₹0 (GMP) = ₹— (Estimated Listing Price).
This is an unofficial grey market estimate based on current demand and may change before listing.

Q: What is the Kostak rate and Subject to Sauda for Molbio Diagnostics IPO?

The Kostak rate is the price at which someone buys or sells an IPO application before allotment — regardless of whether allotment happens. The Subject to Sauda (STS) rate applies only if allotment is received. For Molbio Diagnostics IPO, Kostak and Subject to Sauda rates are not available via our data source. Check current grey market forums or platforms for live Kostak data. Note: Kostak trading is unofficial and unregulated by SEBI.

Q: When is the listing date and allotment date for Molbio Diagnostics IPO?

The allotment for Molbio Diagnostics IPO is expected to be finalised on —. The stock is scheduled to list on BSE, NSE on 17 Aug 2026.

Q: Is Molbio Diagnostics IPO GMP positive or negative today?

Molbio Diagnostics IPO GMP is neutral (₹0 GMP). No significant grey market activity yet. Neutral signal.

Q: Is the GMP of Molbio Diagnostics IPO reliable for deciding whether to apply?

No. While GMP reflects current market sentiment and demand in the informal grey market, it is unregulated by SEBI and fluctuates daily based on market conditions. GMP for SME IPOs can be especially unreliable due to thin market participation. Always evaluate company fundamentals — PAT, revenue growth, P/E ratio vs peers, debt-to-equity ratio, and promoter holding — before applying. QIB subscription level is a more reliable institutional sentiment indicator.

Q: What is the minimum investment for Molbio Diagnostics IPO?

Minimum investment details will be available once the issue price is finalised.

Q: What is the issue price and price band of Molbio Diagnostics IPO?

Molbio Diagnostics IPO price band is ₹— with the upper end (issue price) fixed at ₹— per share. Lot size is — shares. Minimum retail application: 1 lot at ₹—.

Data powered by IPO Guru. Last updated: 4 Aug 2026 10:02 AM IST.

Related:
Live IPO GMP Today →  | 
What is IPO GMP? →  | 
What is P/E Ratio? →  | 
What is PAT? →